Abstract
Monitoring of HF (heart failure) with intracardiac pressure, intrathoracic impedance and/or natriuretic peptide levels has been advocated. We aimed to investigate possible differences in the response patterns of each of these monitoring modalities during HF decompensation that may have an impact on the potential for early therapeutic intervention. Six sheep were implanted with a LAP (left atrial pressure) sensor and a CRT-D (cardiac resynchronization therapy defibrillator) capable of monitoring impedance along six lead configuration vectors. An estimate of A(LAP) (LAP from admittance) was determined by linear regression. HF was induced by rapid ventricular pacing at 180 and 220 bpm (beats/min) for a week each, followed by a third week with daily pacing suspensions for increasing durations (1-5 h). Incremental pacing induced progressively severe HF reflected in increases in LAP (5.9 +/- 0.4 to 24.5 +/- 1.6 mmHg) and plasma atrial (20 +/- 3 to 197 +/- 36 pmol/l) and B-type natriuretic peptide (3.7 +/- 0.7 to 32.7 +/- 5.4 pmol/l) (all P < 0.001) levels. All impedance vectors decreased in proportion to HF severity (all P < 0.001), with the LVring (left ventricular)-case vector correlating best with LAP (r(2) = 0.63, P < 0.001). Natriuretic peptides closely paralleled rapid acute changes in LAP during alterations in pacing (P < 0.001), whereas impedance changes were delayed relative to LAR A(LAP) exhibited good agreement with LAR In summary, impedance measured with an LV lead correlates significantly with changes in LAP, but exhibits a delayed response to acute alterations. Natriuretic peptides respond rapidly to acute LAP changes. Direct LAP, impedance and natriuretic peptide measurements all show promise as early indicators of worsening HE A(LAP) provides an estimate of LAP that may be clinically useful.